NPTX2 and Alzheimer disease: Notably, NPTX2 has been reported as an AD-associated CSF inflammatory biomarker that better predicts disease pathology than other immunological markers and clearly shows measurable temporal wasting and memory loss (Swanson and Willette, 2016).